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Summary The disease-free probabilities after 3 to 7 years of follow-up of 180 breast cancers of known
doubling times were studied to assess the prognostic significance and clinical implications of the growth
characteristics of primary breast cancer. Fast-growing tumours, N+ >3, showed a prognosis significantly
worse (P<0.01) than that of slow-growing tumours of the same class; no significant differences were found
among N- or N+ (1-3) fast-, intermediate- and slow-growing tumours. Highly significant differences were
found among fast- and intermediate-growing tumours with different degrees of lymph node involvement
(respectively P<0.0001 and P<0.001), with the worst prognosis for N+ >3 tumours. In contrast, no
significant differences were found among slow-growing tumours of the different N classes. When the Cox
model was applied, the relationship between lymph node involvement and doubling time was significant, as
was the interaction term. It is suggested that growth rate and metastatic potential are not the same in primary
breast cancers, and their relation should be investigated.
The prognostic significance of the mammary
tumour growth rate has been evaluated in some
retrospective studies (Kusama et al., 1972; Pearl-
man, 1976; Slack et al., 1969; Spratt et al., 1977,
1983), and a relation between patient survival and
the tumour growth rate recognized. Nevertheless,
the growth rate, normally expressed as mass
tumour doubling time (DT), is not a prognostic
parameter used in clinical practice because of the
difficulty of evaluating it in the usually short time
preceding surgical treatment.
This paper reports the results of a prospective
study of 180 breast cancers followed since 1975, for
which the growth rate was evaluated before surgical
treatment by means of a double mammographic
examination. The aim of this study was to assess
the biological meaning of the growth rate and its
clinical implications. Owing to the relatively short
average follow-up, our analysis was related to the
disease-free interval, and the reported results should
be considered as preliminary.
Materials and methods
From 1975 to 1980, 196 breast cancers in patients
attending the Outpatient Department of the Istituto
Nazionale Tumori of Milan were collected. Each
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woman had to have two mammographic examin-
ations with an interval of more than 20 days. The
delays before the intervention were mainly due to
the time required for staging examinations or de-
layed admission because of a long waiting list for
hospitalization.
Mammographic examinations, performed in two
perpendicular projections for each side, revealed the
iconographic characteristics (borders, opacity,
shape, microcalcifications) as well as the size of the
neoplasm along three perpendicular axes in the case
of clearly defined radiological images (more than
95% in our series). The mammographic volume
was estimated using the formula for spheroids:
V=4/3irabc (1)
where a, b and c are the radii derived from the
three axes of the tumour. Since two depth values
were obtained (one from the craniocaudal position
and the other from the latero-lateral projection),
the mean of these two values was used. If the
neoplastic shadow was clearly identifiable only in
one projection, then the volume was calculated
using the smaller radius as the third dimension.
The growth rate, expressed as actual DT, was
calculated on the assumption of exponential growth
(Spratt et al., 1977), i.e.
0.69315 DT= ax
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where
In V1-In VO aX= T, -To
where VO and V1 are the estimated mammographic
tumour volumes at time To (first examination) and
T1 (second examination, just before the surgical
intervention), respectively. T1-T0, the interval be-
tween the two examinations, was 30 days on the
average. The justification for this procedure has
been reported in detail elsewhere (Galante et al.,
1981).
On the basis of DT values, expressed in days, the
case material was conventionally divided as follows:
fast-growing (DT up to 30 days), intermediate-
growing (DT from 31 to 90 days), and slow-
growing tumours (DT more than 90 days. Figure 1
shows the distribution of the original case material.
Sixteen cases were excluded from the follow-up for
the following reasons: two for the appearance of a
second tumour other than breast cancer, two
because death occurred from causes other than
cancer, and 12 because only a biopsy was per-
formed owing to the advanced stage of the tumour
or the poor clinical condition of the patient. The
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follow-up was evaluated for the remaining 180
patients who underwent radical mastectomy with
lymph node dissection: N- cases underwent sur-
gery only; N+ cases underwent surgery plus adju-
vant chemotherapy (CMF regimen: cyclophos-
phamide, methotrexate, 5-fluorouracil).
The disease-free survival probabilities of the case
material were evaluated in relation to T stage,
histologic N stage, and DT subgroups, and esti-
mated by means of the product limit method (Peto
et al., 1977). Moreover, the significance of the
prognostic parameters N and DT and of their
interaction was evaluated by means of the Cox
model (Cox, 1972).
Results
The disease-free probabilities after 3 to 7 years of
follow-up of the 180 patients evaluated according
to T and N stage and to the DT subdivision
showed the following results: (a) no significant
difference between the disease-free probabilities of
TI and T2 cases (0.1>P>0.05); (b) a significant
difference (P<0.001) among the disease-free
probabilities of the three N groups (N-, N+ 1-3,
Doubling - time (in days)
Figure 1 Doubling time distribution of 196 breast cancers. Solid columns, fast, 31 patients (15.8%); white
columns, intermediate, 84 patients (42.9%); barred columns, slow, 81 patients (41.3%).
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Table I Disease-free probabilities of 180 breast cancers after 36-84 months of follow-up
(growth rate vs. lymph node involvement).
N- N+ (1-3) N+ (>3)
Doubling time Rela DF (%) Rel DF (%) Rel DF (%) pb
Fast 3/16 80 2/6 66 6/6 0 0.0001
Intermediate 4/23 80 11/35 59 13/19 31 0.001
Slow 7/43 77 4/21 68 5/11 51 0.2
PC 0.9 0.7 0.01
aRel, relapses: DF, disease-free probability; bp values refer to the comparison among
values of the DF line; CP values refer to the comparison among values of the DF column.
N+ >3); (c) no significant difference among the
disease-free probabilities of the three subsets of
growth. Further analysis of disease-free probabil-
ities of the three DT subsets allowing for TI and
T2 stages did not show any significant difference.
In contrast, the same analysis allowing for the three
N stages (Table I) showed a significant difference
(P<0.01) among the disease-free probabilities of
the three N+ >3 DT subsets, but not among those
of the three N- or N+ 1-3 DT subsets.
Moreover, comparison of the disease-free probabil-
ities of the three groups of lymph node invovle-
ment, allowing for the three DT subsets, showed a
statistical significance for fast-growing and
intermediate-growing cases, but not for slow-
growing cases.
The relation between growth rate and lymph
node involvement was investigated using the Cox
model, including the interaction term. Lymph node
and interaction terms were significant, as was the
growth rate when the interaction term was removed
from the model. Figure 2, based on the results of
the Cox model, clearly shows the relation between
lymph node involvement and growth rate in the
prognosis of breast cancer; the N- fast-growing
11
4/21
s ul
Figure 2 Relapse risk of 180 breast cancers
distributed according to the doubling time and lymph
node involvment. Number of cases at risk. RR,
relaspse risk; f, fast; i, intermediate; s, slow. (O), N-;
(*) N+(1-3); (O), N+(>3).
subset (which showed the highest disease-free
probability) had a relapse risk equal to 1.
Discussion
The starting hypothesis was that if the growth rate
were predictive of the course of the disease
(Kusama et al., 1972; Pearlman, 1976; Slack et al.,
1969; Spratt et al., 1983), it would be apparent
during the follow-up, both in terms of disease-free
survival and of overall survival probabilities.
However, in our study, no significance was found
in the comparison of the disease-free probabilities
of the whole case material distributed according to
the three subsets of growth. A correct procedure
should take into account the stage of the disease
and the interference of the therapies, Consequently,
the significance of the growth rate needed to be
evaluated on a series homogeneous for stage and
therapy. As the therapy is normally planned ac-
cording to N staging, the significance of the growth
rate was re-examined in the three subsets of lymph
node involvement (N-, N+ 1-3, N+ >3). Since
there were no significant differences in the follow-
up of patients who underwent different surgical
procedures (radical mastectomy or quadrantectomy)
in our institution (Veronesi et al., 1985), no in-
fluence was expected on the statistical analyses.
Moreover, because of the short follow-up, the ana-
lysis was limited to disease-free probabilities.
No definite conclusions can be drawn from our
results, since the follow-up was far shorter than the
20 years considered by Hibberd et al. (1983) neces-
sary for a realistic view of the natural history of
breast cancer. However, relapse is important as the
first event in the natural history of the disease after
radical treatment that the physician encounters and
for which a new therapeutic approach must be
planned. Although a comparison of our findings
with those of the literature is not possible because
only retrospective studies have been reported, three
results of the follow-up of our series are note-
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worthy. Firstly, in the N+ >3 cases the course of
the slow-growing tumours was clearly better than
that of the fast-growing tumours. Since involvement
of more than 3 lymph nodes is considered as proof
of disease which is no longer localized, our obser-
vation suggests that at this stage the course of the
disease could be fairly accurately predicted accord-
ing to the growth characteristics of the primary
tumour.
Secondly, no differences were evident among
disease-free probabilities of the three N groups of
slow-growing tumours. Without emphasizing this
result, the course of slow-growing tumours does not
seem to be strictly dependent on lymph node
involvement in a short follow-up.
Thirdly, the disease-free probabilities of the three
N - subsets of growth remain similar after 3 to 7
years of follow-up. After a local treatment (surgery
alone or surgery plus radiotherapy), which is there-
fore not able to modify the biological predeterminism
of the disease, fast-growing tumours were expected
to relapse quickly. Their surprising behaviour sug-
gests different hypotheses. (a) Assuming that fast-
growing tumours have a short preclinical phase,
early treatment could eradicate still localized disease
and change their prognosis. In fact, all the TI N-
cases in our series are alive without disease. (b) If
there are different courses of disease (fast, inter-
mediate and slow, or acute, subacute and chronic),
a different metastatic potential (high or low) could
be supposed for each class of disease. Early treat-
ment of a fast-growing tumour with a low meta-
static potential could mean a very good prognosis.
In conclusion, primary breast cancers have differ-
ent growth characteristics, which are of prognostic
significance when the disease is no longer localized.
Lymph node involvement is associated with the
probability of distant metastases, but it is not proof
that the disease is aggressive; its prognostic sig-
nificance is high for fast- and intermediate-growing
tumours, but low for slow-growing tumours.
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